GVR Report cover Fertility Test Market Share & Trends Report

Fertility Test Market Share & Trends Analysis Report By Product Type (Fertility Monitors, Ovulation Prediction Kits), By Application (Female Fertility, Male Fertility), By Mode of Purchase, By End-use, By Region, And Segment Forecasts, 2023 To 2030

  • Historical Data: ---
  • Forecast Period: 1 - 2030 
  • Industry: Healthcare

Fertility test is a way for doctors to check if someone can have a baby naturally. Age is an important factor that can affect someone's ability to have a baby, so if someone is over 35 and has not been able to get pregnant after six months of trying, they might need fertility testing. These tests involve talking to a doctor about medical history and doing some blood tests and easy procedures. Women take an ovulation test, which looks for certain hormones in their blood, urine, or saliva, while men have a semen analysis to check how many healthy sperm they have.

Numerous reasons have contributed to the expansion of the fertility test market. One of the significant contributing causes is the rise in disorders such as polycystic ovary syndrome (PCOS), which can cause irregular ovulation. To assess their chances of getting pregnant, more women may decide to undergo fertility testing. In addition, the market growth for fertility tests is boosted by the increasing awareness of the importance of such testing in both developed and developing countries. Many companies and organizations now organize camps and events annually to raise awareness among individuals about fertility tests. Furthermore, the introduction of technologically advanced products and changes in lifestyle also contribute to the market's growth. For instance, in March 2020, the at-home ovulation testing kit developed by Proov has been granted approval by the FDA. The kit assesses the existence of PdG, a urine metabolite of progesterone that is released by the ovary after ovulation. Women can use this testing kit at home to determine if they have ovulated or not. This information is important for women who want to conceive, as it helps them identify the ideal time to attempt pregnancy.

The COVID-19 outbreak has significantly impacted the global fertility test market as authorities initially advised against in-person fertility testing services in the early stages of the pandemic. This led to a decline in demand for fertility testing services as people were unable to access these services due to the restrictions. In addition, the disruption of global supply chains and the imposition of travel restrictions also affected the market negatively. For instance, in March 2020, to minimize the spread of COVID-19, the American Society of Reproductive Medicine recommended the suspension of all in-person fertility treatments in the U.S., which has adversely impacted the growth of the fertility test market. This measure was taken to ensure the safety of patients and healthcare workers and to prioritize essential medical care during the pandemic. The interruption of in-person treatments resulted in reduced demand for fertility tests, leading to a decline in market growth.

The market for fertility tests is expected to be growing significantly in North America due to the increasing use of fertility monitoring devices for birth control, rising awareness of the benefits of ovulation monitors through social media, marketing campaigns, and e-commerce sites, declining fertility rates, increasing age of first-time pregnancies, and high prevalence of polycystic ovary syndrome (PCOS) in the region. In addition, Europe is expected to experience a rapid and profitable growth rate during the forecast period due to the increasing population, adoption of advanced technologies, and changes in lifestyle.

Fertility Test Market Segmentation

  • By Product Type

    • Fertility Monitors

    • Ovulation Prediction Kits

    • Male Fertility Testing Products

  • By Application

    • Female Fertility

    • Male Fertility

  • By Mode of Purchase

    • OTC-based

    • Prescription-based

  • By End Use

    • Hospitals & Fertility Clinics

    • Home Care Facility

  • By Region
    • North America
      • U.S.
      • Canada
    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Thailand

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

  • Key Players

    • Fertility Focus Limited

    • Geratherm Medical AG

    • Church & Dwight Co., Inc.

    • Fairhaven Health, LLC

    • Quidel Corporation

    • AdvaCare Pharma

    • UEBE Medical GmbH

    • Prestige Consumer Healthcare Inc.

    • LA Medical Wholesale

    • ExSeed Health

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.